Nacolomab tafenatox

Revision as of 20:21, 27 September 2011 by WikiBot (talk | contribs) (Protected "Nacolomab tafenatox": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Drugbox-mab

WikiDoc Resources for Nacolomab tafenatox

Articles

Most recent articles on Nacolomab tafenatox

Most cited articles on Nacolomab tafenatox

Review articles on Nacolomab tafenatox

Articles on Nacolomab tafenatox in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Nacolomab tafenatox

Images of Nacolomab tafenatox

Photos of Nacolomab tafenatox

Podcasts & MP3s on Nacolomab tafenatox

Videos on Nacolomab tafenatox

Evidence Based Medicine

Cochrane Collaboration on Nacolomab tafenatox

Bandolier on Nacolomab tafenatox

TRIP on Nacolomab tafenatox

Clinical Trials

Ongoing Trials on Nacolomab tafenatox at Clinical Trials.gov

Trial results on Nacolomab tafenatox

Clinical Trials on Nacolomab tafenatox at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Nacolomab tafenatox

NICE Guidance on Nacolomab tafenatox

NHS PRODIGY Guidance

FDA on Nacolomab tafenatox

CDC on Nacolomab tafenatox

Books

Books on Nacolomab tafenatox

News

Nacolomab tafenatox in the news

Be alerted to news on Nacolomab tafenatox

News trends on Nacolomab tafenatox

Commentary

Blogs on Nacolomab tafenatox

Definitions

Definitions of Nacolomab tafenatox

Patient Resources / Community

Patient resources on Nacolomab tafenatox

Discussion groups on Nacolomab tafenatox

Patient Handouts on Nacolomab tafenatox

Directions to Hospitals Treating Nacolomab tafenatox

Risk calculators and risk factors for Nacolomab tafenatox

Healthcare Provider Resources

Symptoms of Nacolomab tafenatox

Causes & Risk Factors for Nacolomab tafenatox

Diagnostic studies for Nacolomab tafenatox

Treatment of Nacolomab tafenatox

Continuing Medical Education (CME)

CME Programs on Nacolomab tafenatox

International

Nacolomab tafenatox en Espanol

Nacolomab tafenatox en Francais

Business

Nacolomab tafenatox in the Marketplace

Patents on Nacolomab tafenatox

Experimental / Informatics

List of terms related to Nacolomab tafenatox

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Nacolomab tafenatox is a mouse monoclonal antibody and which it is used to treat colorectal cancer. Nacolomab has a chelator, tafenatox.


Template:Mousemonoclonals Template:SIB Template:WH Template:WikiDoc Sources